FSD Pharma Inc Beta
Was ist das Beta von FSD Pharma Inc?
Beta von FSD Pharma Inc ist 1.27
Was ist die Definition von Beta?
BETA gibt an, ob eine Aktie mehr oder weniger schwankungsanfällig ist als der Gesamtmarkt. Ein Beta von weniger als 1 zeigt an, dass die Aktie weniger schwankungsanfällig ist als der Markt, während ein Beta von mehr als 1 anzeigt, dass die Aktie mehr schwankungsanfällig ist. Die Schwankungsanfälligkeit wird als Schwankung des Preises um den Mittelwert gemessen.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta von Unternehmen in Technology Sektor auf NASDAQ im Vergleich zu FSD Pharma Inc
Was macht FSD Pharma Inc?
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.
Unternehmen mit beta ähnlich FSD Pharma Inc
- Axos hat Beta von 1.27
- Ferroglobe Plc hat Beta von 1.27
- Transocean Ltd hat Beta von 1.27
- BlackRock hat Beta von 1.27
- BlackRock hat Beta von 1.27
- Springfield Properties Plc hat Beta von 1.27
- FSD Pharma Inc hat Beta von 1.27
- Golden Valley Mines hat Beta von 1.27
- Golden Valley Mines hat Beta von 1.27
- Sotera Health Co hat Beta von 1.27
- Tribune Publishing hat Beta von 1.27
- Plutus PowerGen Plc hat Beta von 1.27
- Lennar hat Beta von 1.27